OMER240517P1000
- 0.27
- 0.000.00%
Omeros Newsroom
Health Care Flat as Momentum Wanes -- Health Care Roundup
Health-care companies were flat as momentum in the sector stalled. Obesity drug maker Novo Nordisk and Eli Lilly gave back some of their recent gains. Omeros shares tumbled after the clinical-stage b
Why Fluent Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Fluent Inc (NASDAQ:FLNT) fell sharply during Thursday's session after posting weaker-than-expected quarterly results.Fluent posted adjusted loss of 30 cents per share, versus market expectat
SYTA, DATS and CYN Among Mid-day Movers
12 Health Care Stocks Moving In Thursday's Intraday Session
GainersLucy Scientific Discovery (NASDAQ:LSDI) shares moved upwards by 205.8% to $1.56 during Thursday's regular session. The company's market cap stands at $2.7 million. SINTX Techs (NASDAQ:SINT) sha
Express News | Omeros Shares Down 20.4% After Q1 Results
Omeros Plunges 20% Following Q1 Report, Drug Update
Express News | Omeros Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 Adjusted EPS Results
Express News | Needham Reiterates Hold on Omeros
Omeros Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/16/2024 — Needham Reiterates → Hold 11/10/2023 — Cantor Fitzgerald Downgrades Overweight → Neutral 12
Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), Cullinan Management (CGEM) and Omeros (OMER)
Omeros (OMER) Gets a Hold From Needham
Omeros | 10-Q: Quarterly report
Omeros 1Q Loss/Shr 63c >OMER
Omeros 1Q Loss/Shr 63c >OMER
Express News | Omeros Corporation Q1 Net Income USD -37.2 Million
Express News | Omeros Corporation Q1 EPS USD -0.63
Express News | Omeros Corporation Reports First Quarter 2024 Financial Results
Express News | Omeros Corporation Q1 Net Income Continuing Operations USD -43.9 Million
Notable Earnings After Wednesday's Close
Omeros Corporation to Announce First Quarter Financial Results on May 15, 2024
Omeros Corporation (NASDAQ: OMER), today announced that the company will issue its financial results for the quarter and year ended March 31, 2024, on Wednesday, May 15, 2024, after the market closes. Omeros management will host a conference call and webcast that same day at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss the financial results as well as recent developments and highlights.
Omeros Corporation Announces Upcoming Presentations at 2024 European Hematology Association (EHA) Hybrid Congress
Omeros Corporation (Nasdaq: OMER) today announced that interim analysis data from its ongoing Phase 2 study of OMS906 in patients with paroxysmal nocturnal hemoglobinuria submitted to the 2024 European Hematology Association (EHA) Hybrid Congress has been selected for podium presentation.